Methodological quality assessment of clinical practice guidelines for cervical cancer in China from 2014 to 2018_Chinese Journal of Evidence-Based Medicine

Authors：

HU Feifei ¹ , HE Junyong ² ,  HE Lixia ¹ , CAO Yanpei ¹ , LIU Yun ¹

1. Department of gynaecology and obstetrics, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen, 518055, P.R.China;
2. Health Management Center of West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding author：

HE Lixia, Email: hehelixia@163.com

Keywords：

Cervical cancer; Clinical practice guideline; Consensus; Quality assessment; AGREE Ⅱ

DOI：

10.7507/1672-2531.201901032

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To assess the methodological quality of clinical practice guidelines of cervical cancer in China published from 2014 to 2018.Methods CNKI, WanFang Data, CBM, VIP, Medlive.cn, the National Guideline Clearinghouse, PubMed, The Cochrane Library and EMbase were searched for cervical cancer clinical practice guidelines published in China from January 1^st, 2014 to December 31^st, 2018. Four reviewers searched and selected the literature independently according to the inclusion and exclusion criteria and assessed the methodological quality of the included guidelines by using AGREE Ⅱ.Results A total of 9 guidelines were included. The average score for each area was: scope and purpose 75.47%, stakeholders’ involvement 35.09%, the rigor of development 43.70%, clarity of presentation 87.74%, applicability 80.76%, and editorial independence 0%.Conclusions The quality of cervical cancer clinical practice guidelines in China requires further improvement.

Citation： HU Feifei, HE Junyong, HE Lixia, CAO Yanpei, LIU Yun. Methodological quality assessment of clinical practice guidelines for cervical cancer in China from 2014 to 2018. Chinese Journal of Evidence-Based Medicine, 2019, 19(8): 989-993. doi: 10.7507/1672-2531.201901032 Copy

1.	WHO. World Cancer Report 2014. Available at: http://www.iarc.fr/en/publications/books/wcr/wcr-order.php.
2.	Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359-E386.
3.	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
4.	Shekelle PG. Clinical practice guidelines: what's next? JAMA, 2018, 320(8): 757-758.
5.	Brouwers M, Kho ME, Browman GP, et al. AGREE Ⅱ: Advancing guideline development, reporting and evaluation in healthcare. J Clin Epidemol, 2010, 63(12): 1308-1311.
6.	Appraisal of guidelines for research & evaluation Ⅱ instrument. Available at: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.
7.	IOM. Clinical practice guidelines we can trust. Washington, DC: The National Academies Press, 2011.
8.	中华预防医学会妇女保健分会更年期保健学组. 更年期妇女保健指南(2015年). 实用妇科内分泌杂志, 2016, 3(2): 21-32.
9.	国家卫生计生委妇幼健康服务司委托中华预防医学会妇女保健分会. 子宫颈癌综合防控指南. 北京: 人民卫生出版社, 2017.
10.	中华医学会放射学分会宫颈癌专家组. 宫颈癌磁共振检查及诊断规范专家共识. 肿瘤影像学, 2017, 26(4): 250-254.
11.	福建省海峡两岸精准医学协会HPV感染疾病专业委员会. HPV感染疾病相关问题专家共识(2017). 医学研究生学报, 2017, 30(12): 1238-1241.
12.	中国优生科学协会阴道镜和宫颈病理学分会(CSCCP)专家委员会. 中国子宫颈癌筛查及异常管理相关问题专家共识(一). 中国妇产科临床杂志, 2017, 18(2): 190-192.
13.	中国优生科学协会阴道镜和宫颈病理学分会(CSCCP)专家委员会. 中国子宫颈癌筛查及异常管理相关问题专家共识(二). 中国妇产科临床杂志, 2017, 18(3): 286-288.
14.	中国医师协会检验医师分会妇科肿瘤检验医学专家委员会. 妇科肿瘤标志物应用专家共识. 山东大学学报(医学版), 2018, 56(10): 1-8.
15.	魏丽惠, 赵昀, 谢幸, 等. 妊娠合并子宫颈癌管理的专家共识. 中国妇产科临床杂志, 2018, 19(2): 190-192.
16.	中国抗癌协会妇科肿瘤专业委员会. 宫颈癌诊断与治疗指南(第四版). 中国实用妇科与产科杂志, 2018, 34(6): 613-622.
17.	Zeng ZY, Yang HT, Li ZB, et a1. Prevalence and genotype distribution of hpv infection in China: analysis of 51, 345 HPV genotyping results from China's largest CAP certified laboratory. J Cancer, 2016, 7(9): 1037-1043.
18.	徐信, 陈邦, 左瑞东, 等. 中国胃癌临床实践指南的质量评价. 中国循证医学杂志, 2018, 18(8): 865-870.
19.	李琴, 刘非, 魏永刚, 等. 2016-2017年中国肝癌临床实践指南的质量评价. 中国循证医学杂志, 2018, 18(10): 1109-1113.
20.	蒋朱明, 詹思延, 贾小魏, 等. 制订/修订《临床诊疗指南》的基本方法及程序. 中华医学杂志, 2016, 96(4): 250-253.
21.	林夏, 杨克虎, 陈耀龙, 等. 中国临床实践指南的现状与思考. 中国循证医学杂志, 2017, 17(5): 497-500.
22.	世界卫生组织. 世界卫生组织指南制订手册. 杨克虎, 译. 兰州: 兰州大学出版社, 2013.
23.	陈耀龙, 杨克虎, 田金徽, 等. 循证实践指南的制订: 国际经验与中国实践. 兰州大学学报(医学版), 2016, 42(1): 29-35.
24.	韦当, 王聪尧, 肖晓娟, 等. 指南研究与评价(AGREE Ⅱ)工具实例解读. 中国循证儿科杂志, 2013, 8(4): 316-319.
25.	陈耀龙, 胡嘉元, 李承羽, 等. 中国临床实践指南的发展与变革. 中国循证医学杂志, 2018, 18(8): 787-792.

1. WHO. World Cancer Report 2014. Available at: http://www.iarc.fr/en/publications/books/wcr/wcr-order.php.
2. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359-E386.
3. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
4. Shekelle PG. Clinical practice guidelines: what's next? JAMA, 2018, 320(8): 757-758.
5. Brouwers M, Kho ME, Browman GP, et al. AGREE Ⅱ: Advancing guideline development, reporting and evaluation in healthcare. J Clin Epidemol, 2010, 63(12): 1308-1311.
6. Appraisal of guidelines for research & evaluation Ⅱ instrument. Available at: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.
7. IOM. Clinical practice guidelines we can trust. Washington, DC: The National Academies Press, 2011.
8. 中华预防医学会妇女保健分会更年期保健学组. 更年期妇女保健指南(2015年). 实用妇科内分泌杂志, 2016, 3(2): 21-32.
9. 国家卫生计生委妇幼健康服务司委托中华预防医学会妇女保健分会. 子宫颈癌综合防控指南. 北京: 人民卫生出版社, 2017.
10. 中华医学会放射学分会宫颈癌专家组. 宫颈癌磁共振检查及诊断规范专家共识. 肿瘤影像学, 2017, 26(4): 250-254.
11. 福建省海峡两岸精准医学协会HPV感染疾病专业委员会. HPV感染疾病相关问题专家共识(2017). 医学研究生学报, 2017, 30(12): 1238-1241.
12. 中国优生科学协会阴道镜和宫颈病理学分会(CSCCP)专家委员会. 中国子宫颈癌筛查及异常管理相关问题专家共识(一). 中国妇产科临床杂志, 2017, 18(2): 190-192.
13. 中国优生科学协会阴道镜和宫颈病理学分会(CSCCP)专家委员会. 中国子宫颈癌筛查及异常管理相关问题专家共识(二). 中国妇产科临床杂志, 2017, 18(3): 286-288.
14. 中国医师协会检验医师分会妇科肿瘤检验医学专家委员会. 妇科肿瘤标志物应用专家共识. 山东大学学报(医学版), 2018, 56(10): 1-8.
15. 魏丽惠, 赵昀, 谢幸, 等. 妊娠合并子宫颈癌管理的专家共识. 中国妇产科临床杂志, 2018, 19(2): 190-192.
16. 中国抗癌协会妇科肿瘤专业委员会. 宫颈癌诊断与治疗指南(第四版). 中国实用妇科与产科杂志, 2018, 34(6): 613-622.
17. Zeng ZY, Yang HT, Li ZB, et a1. Prevalence and genotype distribution of hpv infection in China: analysis of 51, 345 HPV genotyping results from China's largest CAP certified laboratory. J Cancer, 2016, 7(9): 1037-1043.
18. 徐信, 陈邦, 左瑞东, 等. 中国胃癌临床实践指南的质量评价. 中国循证医学杂志, 2018, 18(8): 865-870.
19. 李琴, 刘非, 魏永刚, 等. 2016-2017年中国肝癌临床实践指南的质量评价. 中国循证医学杂志, 2018, 18(10): 1109-1113.
20. 蒋朱明, 詹思延, 贾小魏, 等. 制订/修订《临床诊疗指南》的基本方法及程序. 中华医学杂志, 2016, 96(4): 250-253.
21. 林夏, 杨克虎, 陈耀龙, 等. 中国临床实践指南的现状与思考. 中国循证医学杂志, 2017, 17(5): 497-500.
22. 世界卫生组织. 世界卫生组织指南制订手册. 杨克虎, 译. 兰州: 兰州大学出版社, 2013.
23. 陈耀龙, 杨克虎, 田金徽, 等. 循证实践指南的制订: 国际经验与中国实践. 兰州大学学报(医学版), 2016, 42(1): 29-35.
24. 韦当, 王聪尧, 肖晓娟, 等. 指南研究与评价(AGREE Ⅱ)工具实例解读. 中国循证儿科杂志, 2013, 8(4): 316-319.
25. 陈耀龙, 胡嘉元, 李承羽, 等. 中国临床实践指南的发展与变革. 中国循证医学杂志, 2018, 18(8): 787-792.

Previous Article
Quality assessment of clinical practice guidelines on acupuncture
Next Article
Real-world evidence in earthquake emergency medical rescue

Chinese Journal of Evidence-Based Medicine

Methodological quality assessment of clinical practice guidelines for cervical cancer in China from 2014 to 2018

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content